Skip to main content

Table 3 Time era- and age-specific total PCB and congener concentrations in serum

From: Paradoxical increases in serum levels of highly chlorinated PCBs in aged women in clear contrast to robust decreases in dietary intakes from 1980 to 2003 in Japan

Survey year

1980

1995

2003

Total

Age (years)

<40

40–50

>50

<40

40–50

>50

<40

40–50

>50

Birth year (group)

1946 (group C)

1936 (group B)

1924 (group A)

1957 (group D)

1950 (group C)

1934 (group B)

1972 (group E)

1958 (group D)

1948 (group C)

No.

17

12

10

2a

17

21

59

22

9

169

Total PCBs (ng/g lipid)

 GM (GSD)

185 (1.8)

170 (1.4)

125 (1.7)

83 (2.3)

128 (2.0)

164 (1.9)

68 (1.8)A

110 (1.6)B

242 (1.7)C*

113 (2.0)

 Range

60–414

97–306

55–282

46–148

42–714

67–895

18–282

49–221

84–570

18–895

 Q1

105

118

76

–

72

95

43

68

191

66

 Q2

195

180

128

–

115

163

65

112

236

114

 Q3

311

220

175

–

181

222

106

157

356

182

 #

a

ns

ns

–

ns

ns

b

ns

ns

 

CB-74 (ng/g lipid)

 GM (GSD)

18 (1.9)

17 (2.0)

12 (1.9)

5.4 (2.0)

7.4 (1.9)

11 (2.1)

3.0 (1.9)A

4.8 (1.7)B

11 (1.8)C*

6.5 (2.5)

 Range

6.0–40

6.2–40

7.3–67

3.4–8.8

2.6–33

3.0–51

0.8–12

2.0–12

3.8–29

0.8–67

 Q1

10.7

8.8

8.1

–

4.4

6.8

1.9

2.8

8.1

3.3

 Q2

17

15

10.5

–

7.1

11

3.0

5.3

9.4

6.6

 Q3

33

35

12

–

12

18

5.0

7.6

19

12

 #

a

a

ns

–

b

ns

b

b

ns

 

CB-99 (ng/g lipid)

 GM (GSD)

10.0 (1.9)

9.2 (1.5)

5.9 (1.6)

4.1 (1.8)

5.0 (2.2)

6.0 (2.0)

2.8 (1.8)A

3.9 (1.8)A

7.4 (2.1)B*

4.7 (2.2)

 Range

2.9–26

4.7–16

3.6–18

2.7–6.1

1.1–35

1.2–29

0.9–13

0.9–9.8

1.8–22

0.90–35

 Q1

5.6

6.3

4.6

–

3.0

3.7

1.7

2.7

4.4

2.7

 Q2

10.6

9.2

4.9

–

4.1

6.2

2.5

4.4

7.9

4.7

 Q3

18

13

7.5

–

8.6

8.7

4.4

5.7

13

7.9

 #

a

a

ns

–

b

ns

b

b

ns

 

CB-118 (ng/g lipid)

 GM (GSD)

26 (2.0)

22 (1.3)

17 (1.8)

8.8 (1.7)

12 (2.1)

14 (2.1)

5.8 (1.8)A

8.9 (1.6)B

17 (2.1)C*

10.7 (2.2)

 Range

8.4–64

15–37

8.6–53

6.0–13

3.7–107

3.5–79

1.8–16

3.3–17

4.8–56

1.8–107

 Q1

13

16

10.8

–

8.2

10.2

3.7

5.8

10.1

5.8

 Q2

28

23

15

–

10.9

14

5.6

10.2

18

10.9

 Q3

52

28

23

–

17

20

9.1

13

31

16

 #

a

a

ns

–

b

ns

b

b

ns

 

CB-138 (ng/g lipid)

 GM (GSD)

24 (1.9)

23 (1.4)

15 (1.6)

11 (2.1)

15 (2.1)

19 (2.0)

8.3 (1.8)A

13 (1.7)B

27 (1.8)C*

14 (2.1)

 Range

7.8–84

13–45

7.5–33

6.3–18

4.6–121

7.2–167

2.3–31

4.0–27

8.9–64

2.3–167

 Q1

13

16

11

–

9.2

12

5.4

8.1

20

7.9

 Q2

24

24

15

–

13

18

7.8

14

23

14

 Q3

42

29

22

–

24

23

12

20

42

22

 #

a

a

ns

–

ab

ns

b

b

ns

 

CB-146 (ng/g lipid)

 GM (GSD)

6.1 (1.8)

6.0 (1.4)

4.2 (1.7)

3.1 (2.3)

5.1 (2.1)

6.6 (2.0)

2.6 (2.0)A

4.3 (1.7)B

9.7 (1.8)C*

4.2 (2.1)

 Range

2.2–18

3.3–12

1.8–7.3

1.7–5.6

1.7–32

2.5–45

0.5–13

1.5–11

2.8–22

0.5–45

 Q1

3.2

4.4

2.6

–

2.9

3.5

1.6

2.9

7.5

2.6

 Q2

6.5

5.9

4.9

–

4.7

6.3

2.5

4.4

9.9

4.5

 Q3

9.6

8.0

7.1

–

7.4

9.5

4.5

6.2

15

7.2

 #

a

ns

a

–

ns

ab

b

ns

b

 

CB-153 (ng/g lipid)

 GM (GSD)

41 (1.8)

40 (1.4)

28 (1.6)

21 (2.3)

33 (2.1)

42 (2.0)

19 (1.9)A

30 (1.6)B

65 (1.7)C*

29 (2.0)

 Range

15–115

25–81

11–53

12–39

11–188

18–295

4.9–85

12–64

23–152

4.9–295

 Q1

24

28

18

–

20

24

12

19

50

18

 Q2

40

41

29

–

32

39

18

30

65

29

 Q3

65

51

43

–

46

57

28

43

95

47

 #

a

ns

a

–

ns

ab

b

ns

b

 

CB-156 (ng/g lipid)

 GM (GSD)

5.4 (2.0)

4.7 (1.4)

3.4 (1.6)

2.7 (2.6)

4.3 (2.3)

5.2 (2.0)

1.9 (2.0)A

3.3 (1.7)B

8.1 (1.8)C*

3.3 (2.2)

 Range

1.9–18

2.6–08

1.5–6.6

1.4–5.4

1.7–48

1.7–39

0.3–6.8

1.5–7.0

2.7–19

0.3–48

 Q1

3.0

3.6

2.3

–

2.2

3.4

1.1

1.8

5.8

1.9

 Q2

5.0

4.9

3.7

–

3.8

5.0

1.9

3.6

8.4

3.6

 Q3

9.1

6.3

5.3

–

6.5

7.5

3.1

4.6

12

5.5

 #

a

ns

a

–

ns

ab

b

ns

b

 

CB-163 & 164 (ng/g lipid)

 GM (GSD)

10.3 (1.9)

10.3 (1.4)

7.2 (1.6)

4.9 (2.3)

8.2 (2.2)

10.7 (2.0)

4.1 (2.0)A

6.9 (1.6)B

16 (1.7)C*

6.9 (2.1)

 Range

3.4–34

6.6–20

3.0–13

2.7–9.0

2.9–60

4.1–92

0.8–17

3.0–15

5.2–31

0.8–92

 Q1

5.3

7.2

4.4

–

4.5

6.9

2.5

4.6

13

4.1

 Q2

10.2

10.8

7.8

–

7.8

9.2

4.1

7.0

16

7.4

 Q3

18

14

11

–

12

17

7.7

9.4

25

11

 #

a

ns

a

–

ns

ab

b

ns

b

 

CB-170 (ng/g lipid)

 GM (GSD)

5.8 (1.7)

5.0 (1.4)

4.1 (1.7)

3.4 (2.8)

5.2 (2.0)

6.3 (1.8)

2.8 (1.9)A

5.1 (1.5)B

11 (1.6)C*

4.4 (2.0)

 Range

1.9–11

2.8–10

1.5–6.9

1.6–6.9

2.2–22

2.2–23

0.5–12

2.6–10

4.3–22

0.5–23

 Q1

3.5

3.5

2.5

–

2.7

3.9

1.9

3.3

9.4

2.7

 Q2

6.0

5.3

5.1

–

4.8

6.1

2.9

5.5

10.6

4.9

 Q3

9.4

6.0

5.9

–

8.2

10.2

5.0

6.7

16

6.8

 #

a

ns

a

–

ns

a

b

ns

b

 

CB-180 (ng/g lipid)

 GM (GSD)

21 (1.7)

19 (1.5)

16 (1.8)

12 (2.9)

19 (1.9)

24 (1.8)

11 (1.9)A

20 (1.5)B

46 (1.6)C*

17 (2.0)

 Range

7.3–42

10.3–39

5.7–28

5.9–26

7.6–74

8.7–69

2.8–49

10.4–44

20–101

2.8–101

 Q1

14

13

8.6

–

10.2

16

7.2

15

35

10.6

 Q2

24

19

20

–

17

23

10.7

20

46

19

 Q3

31

25

25

–

31

42

20

28

59

26

 #

a

ns

a

–

ns

a

b

ns

b

 

CB-182 & 187 (ng/g lipid)

 GM (GSD)

10.0 (1.7)

9.6 (1.5)

7.2 (1.7)

5.1 (2.7)

8.6 (1.9)

11 (1.9)

5.3 (2.0)A

9.3 (1.7)B

21 (1.9)C*

8.0 (2.0)

 Range

3.7–20

5.4–23

2.8–12

2.5–10.3

2.7–39

4.9–42

0.9–32

3.1–27

6.0–58

0.9–58

 Q1

6.5

6.5

4.1

–

5.1

6.4

3.5

7.2

15

4.9

 Q2

10.2

9.6

9.2

–

8.7

11

5.2

8.9

21

8.7

 Q3

16

12

11

–

14

18

9.7

13

31

13

 #

a

ns

a

–

ns

a

b

ns

b

 

Penta CBs (ng/g lipid)

 GM (GSD)

55 (1.9)

50 (1.5)

27 (1.8)

18 (1.8)

25 (2.1)

32 (2.0)

12 (1.8)A

18 (1.6)B

36 (2.0)C*

22 (2.3)

 Range

17–122

26–86

10–47

12–28

7.4–175

8.8–126

3.6–36

6.3–35

10.4–108

3.6–175

 Q1

29

33

15

–

16

22

7.2

10.9

23

11

 Q2

68

47

34

–

23

35

11

19

38

23

 Q3

101

76

42

–

39

46

18

26

63

36

 #

a

a

ns

–

b

ns

b

b

ns

 

Hexa CBs (ng/g lipid)

 GM (GSD)

87 (1.9)

84 (1.4)

58 (1.6)

43 (2.3)

66 (2.1)

84 (2.0)

36 (1.9)A

57 (1.6)B

127 (1.7)C*

58 (2.0)

 Range

30–265

52–164

25–113

24–77

22–448

35–636

8.9–153

22–119

43–282

8.9–636

 Q1

48

58

38

–

39

48

23

34

99

35

 Q2

87

89

59

–

61

79

33

56

129

56

 Q3

145

106

89

–

93

109

54

83

192

92

 #

a

ns

a

–

ns

ab

b

ns

b

 

Hepta CBs (ng/g lipid)

 GM (GSD)

37 (1.7)

34 (1.5)

35 (1.8)

21 (2.8)

33 (1.9)

42 (1.8)

19 (1.9)A

35 (1.6)B

78 (1.6)C*

30 (2.0)

 Range

13–70

19–71

20–138

10–43

13–131

16–134

4.2–94

18–76

31–181

4.2–181

 Q1

24

23

23

–

18

27

13

24

63

18

 Q2

39

35

30

–

30

39

19

35

75

34

 Q3

58

44

42

–

53

70

35

45

106

45

 #

a

ns

a

–

ns

a

b

ns

b

 
  1. GM geometric mean, GSD geometric standard deviation, Q1 25th percentile, Q2 median, Q3 75th percentile
  2. aThis group was excluded from statistical comparison due to small number participants
  3. * There were significant differences among the three age groups within the same survey year (p < 0.05 by Tukey’s HSD test). Values with a different capital letter differ significantly from each other. For example, a value indicated by A differs from the corresponding values indicated by B or C
  4. #Comparison among the three surveys within the same age group. Values with a different lower-case letter differ significantly from each other